Clinical Trials on HIV Infections - Clinical Trials Registry - ICH GCP

Example: Heart Attack

Clinical Trials on HIV Infections

Total 3731 results

NCT05708014

Recruiting

Personalized Prevention for Couples

Conditions: Hiv, HIV Infections, Sexually Transmitted Infection, Sexually Transmitted Diseases, Sexual Behavior, Risk Reduction
NCT05551273

Recruiting

Study of Oral TLR8 Agonist Selgantolimod on HBsAg in Participants With Both Chronic Hepatitis B and HIV

Conditions: Hepatitis B, HIV Infections
NCT05300035

Not yet recruiting

Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control

Conditions: HIV/AIDS and Infections
NCT03220724

Active, not recruiting

Evaluating the Safety and Immunogenicity of EnvSeq-1 and CH505 M5 gp120 Envs Adjuvanted With GLA-SE in Healthy, HIV-Uninfected Adults

Conditions: HIV Infections
NCT04212091

Completed

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants

Conditions: HIV Infections
NCT05079451

Suspended

Broadly Neutralizing Antibodies 3BNC117-LS & 10-1074-LS to Prevent Relapse During ATI

Conditions: HIV Infections
NCT04790201

Recruiting

Friendship Bench Adaptation to Improve Mental Health & HIV Care Engagement Outcomes Among PLWH and PWID in Vietnam

Conditions: HIV Infections, Behavioral Symptoms, Depression, Anxiety, Opioid-use Disorder, Virus Infection, Immune System Diseases, Opioid Dependence
NCT05510908

Not yet recruiting

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Conditions: HIV-Associated Malignant Neoplasm, HIV Infections, Cancer, AIDS Related Lymphoma, AIDS-related Kaposi Sarcoma, AIDS-Related Malignancy, Anal Cancer, HPV-Related Malignancy
NCT05020899

Enrolling by invitation

Quit For Life (QFL): Smoking Cessation Among Chinese Smokers Living With HIV

Conditions: Smoking Cessation, HIV Infections
NCT04677374

Completed

Uptake of Medical Male Circumcision Among Men With Sexually Transmitted Infections

Conditions: HIV Infections, Sexually Transmitted Infections
NCT03239899

Recruiting

PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection

Conditions: HIV Infections
NCT03600103

Active, not recruiting

Technology Based Community Health Nursing to Improve Combination Anti-Retroviral Therapy (cART) Adherence and Virologic Suppression in Youth Living With HIV

Conditions: HIV Infections, Adherence, Medication
NCT05697289

Not yet recruiting

Satisfaction of HIV-infected Patients Treated With Cabotegravir-rilpivirine Injectable Dual Therapy

Conditions: HIV Infections
NCT03639311

Active, not recruiting

Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study

Conditions: HIV Infections
NCT05140954

Recruiting

The Women TAF-FTC Benchmark Study

Conditions: HIV Infections
NCT04542070

Active, not recruiting

A Study to Evaluate Efficacy and Safety of Cabotegravir (CAB) Long Acting (LA) Plus (+) Rilpivirine (RPV) LA Versus BIKTARVY® (BIK) in Participants With Human Immunodeficiency Virus (HIV)-1 Who Are Virologically Suppressed

Conditions: HIV Infections
NCT04399551

Active, not recruiting

A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries

Conditions: HIV Infections
NCT03299049

Active, not recruiting

Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults

Conditions: HIV Infections
NCT02938520

Active, not recruiting

Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

Conditions: HIV Infections, Glycogen Storage Disease Type II
NCT04900038

Active, not recruiting

A Clinical Trial of GSK3640254 + Dolutegravir (DTG) in Human Immunodeficiency Virus-1 Infected Treatment-naive Adults

Conditions: HIV Infections
NCT04134767

Completed

Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)

Conditions: Substance Use, HIV Infections, HCV Infection, Sexually Transmitted Infections (Not HIV or Hepatitis), Overdose, Drug, Opioid Use
NCT05514509

Recruiting

A Study Evaluating Implementation Strategies for the Delivery of APRETUDE for Black cis-and Transgender Women in United States EHE Territories

Conditions: HIV Infections
NCT05694546

Not yet recruiting

Re-engagement at Discharge 2

Conditions: HIV/AIDS, Hospitalization, Transitions of Care, Opportunistic Infections
NCT05130151

Not yet recruiting

Using Mobile Technology to Prevent HIV and Related Youth Health Problems

Conditions: HIV Infections
NCT04664998

Active, not recruiting

Alignment of PrEP Use With HIV Risk in Young Women and Men

Conditions: Pre-Exposure Prophylaxis, Sexually Transmitted Diseases, Bacterial, HIV Infections